Home Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise

Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise

For this short interview, Emma Cheesman-Ungstrup, Director of Development Consulting and Scientific Affairs at Biopharma Excellence, describes a few of her key takeaways from a panel discussion hosted at Advanced Therapies Week 2022.

Go Back

Start a conversation today

Socials:

First Name*

Last Name*

Telephone

Country

Company Name*

Email*

Your message

Please tick this box to agree to our Privacy Policy.*

Please tick this box if you agree to periodic updates from Biopharma Excellence. If you do not wish to receive any communication from us, you may unsubscribe at any time.